Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo
- 1 April 2006
- journal article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 100 (4), 821-829
- https://doi.org/10.1111/j.1365-2672.2006.02834.x
Abstract
The antagonistic activity of the Escherichia coli strain H22 against enteric bacteria was studied both in vitro and in vivo. In vitro, bacterial strains belonging to seven of nine genera of the family Enterobacteriaceae (Enterobacter, Escherichia, Klebsiella, Morganella, Salmonella, Shigella and Yersinia) were inhibited by the strain H22. Six days after simultaneous oral inoculation in germ-free mice, E. coli strain H22 reduced the faecal population of Shigella flexneri 4 to undetectable levels (P < 0.05). In ex vivo assay, inhibitory zones against Sh. flexneri 4 were observed around faecal samples from mice inoculated with E. coli strain H22. The in vitro inhibition of Sh. flexneri 4 was shown to be mediated by microcin C7. In addition to microcin C7, strain H22 was shown to produce aerobactin, new variants of colicins E1 and Ib, and bacteriophage particles with morphology similar to the phages of the family Myoviridae. Altogether, the properties of E. coli H22, observed both under in vitro and in vivo conditions, suggest its potential use as a probiotic strain for livestock and humans. The strain H22 was shown to produce several antimicrobial compounds with inhibitory capabilities against pathogenic or potentially pathogenic enterobacteria.Keywords
This publication has 27 references indexed in Scilit:
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut, 2004
- Pathogen-Specific Risk Factors and Protective Factors for Acute Diarrheal Illness in Children Aged 12-59 Months in Sao Paulo, BrazilClinical Infectious Diseases, 2004
- The probioticEscherichia colistrain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogensFEMS Immunology & Medical Microbiology, 2004
- Microcin C51 Plasmid Genes: Possible Source of Horizontal Gene TransferAntimicrobial Agents and Chemotherapy, 2003
- Colicins produced by theEscherichia fergusoniistrains closely resemble colicins encoded byEscherichia coliFEMS Microbiology Letters, 2002
- Escherichia coli as a probiotic?Infection, 1998
- Seventy colicin types of shigella sonnei and an indicator system for their determinationZentralblatt für Bakteriologie, 1994
- In vitro studies on the inhibition of the growth of Shigella sonnei by Lactobacillus casei and Lact. acidophilusJournal of Applied Bacteriology, 1992
- The nucleotide sequence of cea* and the region of origin of plasmid pKY-1.The Journal of General and Applied Microbiology, 1986
- ColicinsAnnual Review of Microbiology, 1957